期刊文献+

侵袭性真菌感染风险评分系统的建立及效能分析 被引量:8

Establishment and effectiveness analysis of a risk evaluation system for invasive fungal infections
下载PDF
导出
摘要 目的:建立一个识别侵袭性真菌感染(invasive fungal infection,IFI)高风险人群的风险评分系统,并验证其有效性。方法:对模型组103例病人的病例资料进行单因素及logistic多重回归分析,筛选出IFI的危险因素并分别赋值,建立IFI风险评分系统。运用该评分系统计算41例IFI病人的综合得分,比较各得分组IFI实际发生率的差异,运用接收者工作特征曲线(receiver operating characteristic curve,ROC)评价该评分系统的效能。结果:糖尿病、胃肠道手术、血液系统恶性肿瘤、机械通气治疗>3 d、广谱抗生素治疗>5 d、深静脉导管植入是IFI的危险因素。模型组和验证组中得分越高的病例发生IFI的几率越大,且高、中、低得分组的IFI发生率的差异有统计学意义(P<0.05)。模型组ROC曲线下面积为0.816,验证组ROC曲线下面积为0.811。结论:该评分系统能够有针对性地帮助临床医师识别IFI高风险人群,指导对病人的及时治疗。 Objective: To establish a risk scoring system for identifying patients in high risk of invasive fungal infection(IFI) and analyze its effectiveness.Methods: For the clinical data of 103 patients in the model group,univariate and multivariate logistic regression were used to identify risk factors of IFI.The risk factors were all scored and the IFI risk scoring system(IFIRSS) was established.IFIRSS was used to evaluate the scores of 41 patients in validation group.The evaluation result and actual incidence of IFI in each group were compared.The effectiveness of IFIRSS was analyzed by the receiver operating characteristic curve(ROC).Results: Diabetes mellitus,gastrointestinal operations,hematological malignant tumors,mechanical ventilation longer than 3 days,broad-spectrum antibiotic therapy longer than 5 days and implantation of deep veins catheter were identified as independent risk factors of IFI.Patients with higher scores in model group and validation group were at higher risk of IFI.The difference of IFI incidence between high,middle,and low score groups was significant(P0.05).Area under ROC was 0.816 in model group and 0.811 in validation group.Conclusion: IFIRSS can help clinicians to identify patients at high risk of IFI and guide treatment of patients in time.
作者 廖赟 李玲
出处 《药学服务与研究》 CAS CSCD 2011年第1期15-19,共5页 Pharmaceutical Care and Research
基金 上海市卫生局科研课题资助项目(No.2007080)
关键词 真菌感染 侵袭性 评分系统 风险性 效能分析 fungal infections invasive scoring system risk effectiveness analysis
  • 相关文献

参考文献12

  • 1Pfaller M A,Diekema D J,Messer S A,et al.Activities of fluconazole and voriconazole against 1 586 recent clinical isolates of Candida species determined by broth microdilution,disk diffusion,and E test methods:report from the ARTEMIS Global Antifungal Susceptibility Program,2001[J].J Clin Microbiol,2003,41(4):1440-1446.
  • 2De Pauw B E,Meis J F.Progress in fighting systemic fungal infections in haematological neoplasia[J].Support Care Cancer,1998,6(1):31-38.
  • 3Eubanks P J,de Virgilio C,Klein S,et al.Candida sepsis in surgical patients[J].Am J Surg,1993,166(6):617-620.
  • 4McGuire W,Clerihew L.Austin N.Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants[J].Cochrane Database Syst Rev,2004,(1):CD003850.
  • 5Thomas J C,Madigan M.A retrospective study to evaluate a computer based model for amplifying early anti-fungal intervention and microbial detection of patients at risk for fungemia[C].San Antonio:Seventh Annual Focus on Fungal Infection,1997.
  • 6黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 7侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:863
  • 8Thabane M,Simunovic M,Akhtar-Danesh N,et al.Development and validation of a risk score for post-infectious irritable bowel syndrome[J].Am J Gastroenterol,2009,104(9):2267-2274.
  • 9Koh A Y,K(o)hler J R,Coggshall K T,et al.Mucosal damage and neutropenia are required for Candida albicans dissemination[J].PLoS Pathog,2008,4(2):e35.
  • 10Hedderwick S A.Lyons M J.Liu M,et al.Epidemiology of yeast colonization in the intensive care unit[J].Eur J Clin Microbiol Infect Dis,2000,19(9):663-670.

二级参考文献7

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America.Clin Infect Dis,2000,30:696-709.
  • 3Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
  • 4Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.Lancet Infect Dis,2003,3:230-240.
  • 5Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis.Clin Infect Dis,2004,38:161-189.
  • 6Slavin MA,Szer J,Grigg AP,et al.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.Intern Med J,2004,34:192-200.
  • 7Saag MS,Graybill RJ,Larsen RA,et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America.Clin Infect Dis,2000,30:710-718.

共引文献1223

同被引文献80

  • 1王玫,鲁辛辛,董云秋,谷晔红,孙淑美,田小波,黎卫东.孕妇阴道真菌分布与新生儿感染[J].中国实验诊断学,2006,10(2):191-192. 被引量:3
  • 2侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:863
  • 3张隆群,罗盛淑,王小梅.肝移植术后肺部感染的原因分析及对策[J].重庆医科大学学报,2007,32(7):751-753. 被引量:6
  • 4Ohmagari N, Raad II, Hachem R, et al. Invasive aspergillosis in pa- tients with solid tumors[ J ]. Cancer, 2004, 101 (10) : 2300 - 2302.
  • 5Eyal R, Anat GG, Elad G, et al. Antifungal prophylaxis in cancer pa- tients after chemotherapy or hematopoietic stem - cell transplantation: Systematic review and Meta - analysis [ J]. J Clin Oncol , 2007, 25 (34) : 5471 -5489.
  • 6Pappas PG, Alexander BD, Andes DR, et al. lnvasive fungal infec- tions among organ transplant recipients:Results of the Transplant - As- sociated Infection Surveillance Network (TRANSNET) [ J ]. Clin Infect Dis, 2010, 50(8): 1101-1111.
  • 7Borlenghi E, Cattaneo C, Capucci MA, et al. Usefulness of the MSG/ IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates[ J]. Ann Hematol, 2007, 86 (3) : 205 - 210.
  • 8Maertens J, Marchetti O, Herbrecht R, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell trans- plant recipients : Summary of the ECtL 3 2009 update [ J ]. Bone Marrow Transplant, 2011, 46(5): 709-718.
  • 9Champs- Bro CB, Leroy- Cotteau A, Mazingue F, et al. Invasive fungal infections : Epidemiology and analysis of antifungal prescriptions in onco - haematology [ J ]. J Clin Pharm Ther, 2011,36 ( 2 ) : 152 - 160.
  • 10Ostrosky - Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med, 2006,34 ( 3 ) : 857 - 863.

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部